Overview

Oxytocin Bolus Versus Infusion in Elective Cesarean Section"

Status:
Not yet recruiting
Trial end date:
2023-12-15
Target enrollment:
0
Participant gender:
Female
Summary
Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Stony Brook University
Treatments:
Oxytocin
Criteria
Inclusion Criteria:

- Parturients between the ages of 18 to 45 with singleton pregnancies

- Undergoing elective cesarean section under spinal anesthesia

- American Society of Anesthesia (ASA) physical status class I or II

- Patients must be able to provide written informed consent

Exclusion Criteria:

- Parturients in labor or ruptured membranes

- Multiple gestation

- Risk factors predisposing to uterine atony (history of placenta previa, preeclampsia,
diabetes mellitus macrosomia, hydramnios, bleeding diathesis, uterine fibroids)

- History of uterine atony or postpartum hemorrhage

- History of inherited or acquired coagulation disorders, thrombocytopenia (platelet
count <100), or anemia (hemoglobin < 8)

- History of allergy to oxytocin

- Patients not alert and orientated to person, place, and date. Patient must have, in
the investigator's opinion, the physical and mental capacity to answer survey
questions